By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    headphones can create health problems
    The Harmful Health Effects of Using Headphones
    September 24, 2021
    Headache causes
    4 Causes Of Headache You Probably Didn’t Know About
    December 28, 2021
    follow these steps to recover from your injury
    What Steps Should You Take to Recover More Quickly from an Injury?
    April 12, 2022
    Latest News
    7 Most Common Healthcare Accreditation Programs: Which Should You Use?
    August 20, 2025
    Hospital Pest Control and the Fight Against Superbugs
    August 20, 2025
    Hygiene Beyond The Clinic: Attention To Overlooked Non-Clinical Spaces
    August 13, 2025
    5 Steps to a Promising Career as a Healthcare Administrator
    August 3, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    Key Tips For Buying Safe And Effective CBD Products
    February 16, 2021
    Medical Data & Patient Privacy: An Update
    July 30, 2018
    Benefits Of The Internet Of Things For Hospitals And Healthcare
    September 28, 2020
    Latest News
    How Social Security Disability Shapes Access to Care and Everyday Health
    August 22, 2025
    How a DUI Lawyer Can Help When Your Future Health Feels Uncertain
    August 22, 2025
    How One Fall Can Lead to a Long Road of Medical Complications
    August 22, 2025
    How IT and Marketing Teams Can Collaborate to Protect Patient Trust
    July 17, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Promising Malaria Vaccine
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Global Healthcare > Promising Malaria Vaccine
Global Healthcare

Promising Malaria Vaccine

Amanda Glassman
Amanda Glassman
Share
5 Min Read
SHARE

 

 

News this month that an experimental vaccine cuts in half the risk of malaria in children in Africa is a welcome success story 20+ years in the making. It’s also a rare bright spot in the clinical trials labyrinth that stands between promising new medicines, vaccines, and diagnostic techniques and the one billion people in the developing world who suffer from one or more neglected diseases. Ninety other drug and vaccine candidates for neglected diseases are waiting in the pipeline for late stage clinical development. Under current arrangements, they will face lengthy, inefficient reviews in countries where the regulatory capacity ranges from weak to non-existent.

Related Content

  • Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Diseases (Event)
  • Clinical Trials and Regulatory Pathways for Neglected Diseases (Working Group)

Funding from major donors such as the Bill and Melinda Gates Foundation, Wellcome Trust , Médecins Sans Frontières (MSF) and the World Health Organization has led to an upsurge in new products—including vaccines for diseases like TB, cholera and dengue fever. These funders now face huge costs in bringing the new compounds they helped to develop to market.

More Read

ebola fear
Ebola: America Driven by Fear
Top 5 Reasons Hospitals Are Losing Money
Blue Zones – Can Studying Centenarians Teach Us About Wellness?
Strengthening Global Healthcare Systems Through Public-Private Partnerships
Using EHR systems in healthcare for Cost-Effective Services

Meanwhile, neglected diseases take a heavy toll. Malaria and TB alone kill an estimated 2.1 million people annually, nearly all in low-and middle income countries. Lesser known diseases, like human African trypanosomiasis, chagas disease, leishmaniasis, dengue fever and leprosy kill another half a million people.

These diseases are most widespread precisely where the capacity to test new therapies is most lacking. To assure scientific validity, new compounds must often be tested in several countries, each with their own regulatory authorities and ethical review boards, which are often weak and lacking in transparency.

What does it take to get a new treatment through the pipeline and into the hands of a patient who needs it? A 2008 article in the Lancet cited two examples where trials for TB treatments had been delayed by a year or more due to regulatory hurdles. One trial needed approval from 18 authorities in six countries and was stalled for two years before patient recruitment could begin. Yet the primary drug in this study, Rifapetine, had already been approved by the U.S. Food and Drug Administration (FDA) in 1998.

Unfortunately, this story isn’t unique. In many countries where neglected diseases are endemic, approval of clinical trials can take as long as 6-24 months. For products that require multiple trials in different populations, subsequent application approvals may take an additional 6-24 months or longer. Approval for an amendment to a trial protocol can take up to four months in a low-income setting. In contrast, regulatory approval for trials in the United States and the European Union can generally be obtained within 30-60 days, and trial protocol amendments take only a few weeks.

Long delays in protocol approvals raise costs, eroding the limited funding available to find cures for neglected diseases and bring them to market. According to a recent report by the G-FINDER project, in 2009 the total global spending on TB drug development was just $180 million, with nearly eight out of ten dollars coming from public funders and philanthropic organizations. These scarce funds could go much farther with improved regulatory pathways and clinical trial protocols.

We believe this is a problem that can be fixed. On Monday, October 31st, CGD will release a new report, Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Diseases. Prepared by a CGD working group led by Tom Bollyky and comprising 22 experts from diverse backgrounds including medicine, law, ethics, government, industry, public-private partnerships, and international development, the report offers technically sound and politically feasible recommendations for overcoming the clinical trials labyrinth. We are delighted that FDA Commissioner Margaret Hamburg will kick off the event with a keynote speech.

We hope that you can join us!

This is a joint post with Tom Bollyky

TAGGED:malaria vaccine
Share This Article
Facebook Copy Link Print
Share
By Amanda Glassman
As a healthcare blogger and author, I have been writing about the latest developments in the medical field for over 10 years. My work has been featured on various online publications, including Healthline and WebMD. I am passionate about educating people on how to stay healthy through proper nutrition and exercise practices. In addition to my blog posts, I have also authored several books that focus on health topics such as dieting tips, disease prevention strategies, and mental health awareness initiatives. My goal is to provide readers with reliable information so they can make informed decisions regarding their well-being.

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

engineer fitting prosthetic arm
How Social Security Disability Shapes Access to Care and Everyday Health
Health care
August 20, 2025
a woman explaining the document
How a DUI Lawyer Can Help When Your Future Health Feels Uncertain
Public Health
August 20, 2025
physiotherapist at work
How One Fall Can Lead to a Long Road of Medical Complications
Health care
August 20, 2025
Common Healthcare Accreditation Programs
7 Most Common Healthcare Accreditation Programs: Which Should You Use?
Health News
August 20, 2025

You Might also Like

Millennial Speak: Reaching the Next Generation of Healthcare Consumers

April 21, 2016

Interview: Tiantian Li, Founder of DXY, Chinese Physicians’ Online Community

January 19, 2012
Global HealthcarePublic Health

Diabetes = It must be November

November 1, 2011

The Elusive Power of mHealth

October 4, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?